On a same-center basis, MRI volumes increased nearly 12% year over year, while CT grew by 10%, and PET/CT leapt 14%, the Los Angeles-based company said Wednesday.  

The Danish pharmaceutical company said it will resubmit its application in 2025 to have Wegovy approved for use in heart failure patients.

A survey from KFF survey found the spike in cost will be mitigated by subsidies. However, the number of uninsured Americans could rise.

"Understanding these influences may contribute to optimizing work schedules and decreasing variability," NYU experts wrote in the European Journal of Radiology. 

Medtronic and Abbott are often seen as rivals in a competitive marketplace, but the two companies are collaborating with a simple goal in mind: improving patient access to high-quality CGM devices. 

Ben White, MD, recently soft-launched the service on his blog, highlighting 10 private practices that are hiring around the U.S.

“Reducing the cost and increasing the accessibility of MRI for [clinically significant prostate cancer] is critical for the viability of MRI screening programs," experts wrote. 

The Centers for Medicare & Medicaid Services revealed the news under the 2025 Inpatient Prospective Payment System rule released on Aug. 1